Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection.
Wan-Chen TsaiWei-Ting HsuWang-Da LiuHsin-Yun SunYu-Chung ChuangYu-Shan HuangAristine ChengKuan-Yin LinYi-Chia HuangGuan-Jhou ChenSung-Hsi HuangWang-Huei ShengSzu-Min HsiehChien-Ching HungShan-Chwen ChangPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
In this country of high HBV endemicity, the adverse impact of chronic HBV infection on the survival observed in the pre-TDF era has significantly diminished among HIV/HBV-coinfected patients compared to HIV-monoinfected patients in the era of TDF-containing cART.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- hepatitis b virus
- human immunodeficiency virus
- end stage renal disease
- hiv aids
- hiv infected patients
- ejection fraction
- hepatitis c virus
- chronic kidney disease
- newly diagnosed
- hiv testing
- peritoneal dialysis
- liver failure
- men who have sex with men
- prognostic factors
- emergency department
- patient reported outcomes
- free survival